Non-alcoholic fatty liver disease: further expression of the metabolic syndrome
- PMID: 17295757
- DOI: 10.1111/j.1440-1746.2007.04824.x
Non-alcoholic fatty liver disease: further expression of the metabolic syndrome
Abstract
Non-alcoholic fatty liver disease has been associated with metabolic disorders, including central obesity, dyslipidemia, hypertension and hyperglycemia. Metabolic syndrome, obesity, and insulin resistance are major risk factors in the pathogenesis of non-alcoholic fatty liver disease. Non-alcoholic fatty liver disease refers to a wide spectrum of liver damage, ranging from simple steatosis to non-alcoholic steatohepatitis, advanced fibrosis and cirrhosis.
Similar articles
-
What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?J Gastroenterol Hepatol. 2007 Jun;22(6):794-800. doi: 10.1111/j.1440-1746.2007.04952.x. Epub 2007 May 13. J Gastroenterol Hepatol. 2007. PMID: 17498218
-
Non-alcoholic steatohepatitis and metabolic syndrome.Curr Opin Clin Nutr Metab Care. 2006 Sep;9(5):637-42. doi: 10.1097/01.mco.0000241677.40170.17. Curr Opin Clin Nutr Metab Care. 2006. PMID: 16912563 Review.
-
Review article: the metabolic syndrome and non-alcoholic fatty liver disease.Aliment Pharmacol Ther. 2005 Nov;22 Suppl 2:31-6. doi: 10.1111/j.1365-2036.2005.02592.x. Aliment Pharmacol Ther. 2005. PMID: 16225469 Review.
-
Nonalcoholic fatty liver disease as a complication of insulin resistance.Med Clin North Am. 2007 Nov;91(6):1125-49, ix. doi: 10.1016/j.mcna.2007.06.001. Med Clin North Am. 2007. PMID: 17964913 Review.
-
Metabolic syndrome, non-alcoholic fatty liver disease and hepatitis C virus: impact on disease progression and treatment response.Liver Int. 2009 Mar;29 Suppl 2:3-12. doi: 10.1111/j.1478-3231.2008.01949.x. Liver Int. 2009. PMID: 19187068 Review.
Cited by
-
Synergistic effect of fatty liver and smoking on metabolic syndrome.World J Gastroenterol. 2009 Nov 14;15(42):5334-9. doi: 10.3748/wjg.15.5334. World J Gastroenterol. 2009. PMID: 19908343 Free PMC article.
-
HOMA-IR index in non-diabetic patient, a reliable method for early diagnosis of liver steatosis.Caspian J Intern Med. 2022 Summer;13(3):519-526. doi: 10.22088/cjim.13.3.519. Caspian J Intern Med. 2022. PMID: 35974947 Free PMC article.
-
Clinical, anthropometric, biochemical and histological character of nonalcoholic fatty liver disease without Insulin Resistance.J Clin Exp Hepatol. 2019 Mar-Apr;9(2):176-181. doi: 10.1016/j.jceh.2018.06.011. Epub 2018 Jun 20. J Clin Exp Hepatol. 2019. PMID: 31024199 Free PMC article.
-
The relationship between renal sinus lipomatosis detected at abdominal computed tomography and abdominal visceral and subcutaneous fat accumulation and metabolic risk factors.Pol J Radiol. 2020 Feb 5;85:e62-e66. doi: 10.5114/pjr.2020.93429. eCollection 2020. Pol J Radiol. 2020. PMID: 32467739 Free PMC article.
-
Lipocalin-13 regulates glucose metabolism by both insulin-dependent and insulin-independent mechanisms.Mol Cell Biol. 2011 Feb;31(3):450-7. doi: 10.1128/MCB.00459-10. Epub 2010 Dec 6. Mol Cell Biol. 2011. PMID: 21135134 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical